Insights from a thermography-based method suggesting higher carotid inflammation in patients with diabetes mellitus and coronary artery disease

Diabetes and Metabolism

Volumn 40, Issue 6, 2014, Pages 431-438

  Toutouzas, K ^a   Benetos, G ^a   Drakopoulou, M ^a   Bounas, P ^a   Tsekoura, D ^a   Stathogiannis, K ^a   Koutagiar, I ^a   Aggeli, C ^a   Karanasos, A ^a   Panagiotakos, D ^b   Siores, E ^c   Stefanadis, C ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c UNIVERSITY OF BOLTON   (United Kingdom)

Author keywords

Carotid ultrasound; Coronary artery disease; Diabetes mellitus; Inflammation; Microwave radiometry

Indexed keywords

ADULT; AGED; ARTICLE; CAROTID ARTERY; CAROTID ARTERY DISEASE; CAROTID ARTERY INFLAMMATION; CAROTID ATHEROSCLEROSIS; CAROTID PLAQUE THICKNESS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MICROWAVE RADIOMETRY; PROSPECTIVE STUDY; RADIOMETRY; TEMPERATURE; THICKNESS;

EID: 84919596794     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.05.005     Document Type: Article

References (39)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
2. Kissela B.M., Khoury J., Kleindorfer D., Woo D., Schneider A., Alwell K., et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 2005, 28:355-359.
3. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
4. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:2045-2051.
5. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
6. Ahluwalia N., Blacher J., Szabo de Edelenyi F., Faure P., Julia C., Hercberg S., et al. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease. Atherosclerosis 2013, 228:478-484.
7. Salminen M., Kuoppamaki M., Vahlberg T., Raiha I., Irjala K., Kivela S.L. Does high sensitive CRP improve cardiovascular risk prediction in metabolic syndrome among the aged?. Scand Cardiovasc J 2013, 47:210-216.
8. Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., Gao P., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367:1310-1320.
9. Lee E.J., Kim H.J., Bae J.M., Kim J.C., Han H.J., Park C.S., et al. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. AJNR Am J Neuroradiol 2007, 28:916-919.
10. Vigili de Kreutzenberg S., Tiengo A., Avogaro A. Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. Nutr Metab Cardiovasc Dis 2009, 19:667-673.
11. Kim T.N., Kim S., Yang S.J., Yoo H.J., Seo J.A., Kim S.G., et al. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging 2010, 3:142-148.
12. Bucerius J., Mani V., Moncrieff C., Rudd J.H., Machac J., Fuster V., et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol 2012, 59:2080-2088.
13. Tahara N., Kai H., Yamagishi S., Mizoguchi M., Nakaura H., Ishibashi M., et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007, 49:1533-1539.
14. Marnane M., Merwick A., Sheehan O.C., Hannon N., Foran P., Grant T., et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012, 71:709-718.
15. Rudd J.H., Myers K.S., Bansilal S., Machac J., Woodward M., Fuster V., et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009, 2:107-115.
16. Strobl F.F., Rominger A., Wolpers S., Rist C., Bamberg F., Thierfelder K.M., et al. Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study. Int J Cardiovasc Imaging 2013.
17. Toutouzas K., Benetos G., Drakopoulou M., Michelongona A., Nikolaou C., Masoura C., et al. Morphological and functional assessment of carotid plaques have similar predictive accuracy for coronary artery disease. Stroke 2013, 44:2607-2609.
18. Toutouzas K., Grassos H., Synetos A., Drakopoulou M., Tsiamis E., Moldovan C., et al. A new non-invasive method for detection of local inflammation in atherosclerotic plaques: experimental application of microwave radiometry. Atherosclerosis 2011, 215:82-89.
19. Toutouzas K., Grassos C., Drakopoulou M., Synetos A., Tsiamis E., Aggeli C., et al. First in vivo application of microwave radiometry in human carotids: a new noninvasive method for detection of local inflammatory activation. J Am Coll Cardiol 2012, 59:1645-1653.
20. Toutouzas K., Drakopoulou M., Aggeli C., Nikolaou C., Felekos I., Grassos H., et al. In vivo measurement of plaque neovascularisation and thermal heterogeneity in intermediate lesions of human carotid arteries. Heart 2012, 98:1716-1721.
21. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl 1):S64-S71.
22. Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia. Cerebrovasc Dis 2012, 34:290-296.
23. Bluth E.I., Kay D., Merritt C.R., Sullivan M., Farr G., Mills N.L., et al. Sonographic characterization of carotid plaque: detection of hemorrhage. AJR Am J Roentgenol 1986, 146:1061-1065.
24. Faggioli G.L., Pini R., Mauro R., Pasquinelli G., Fittipaldi S., Freyrie A., et al. Identification of carotid "vulnerable plaque" by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomography. Eur J Vasc Endovasc Surg 2011, 41:238-248.
25. Geroulakos G., Ramaswami G., Nicolaides A., James K., Labropoulos N., Belcaro G., et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg 1993, 80:1274-1277.
26. Saba L., Sanfilippo R., Montisci R., Atzeni M., Ribuffo D., Mallarini G. Vulnerable plaque: detection of agreement between multi-detector-row CT angiography and US-ECD. Eur J Radiol 2011, 77:509-515.
27. Lerakis S., Synetos A., Toutouzas K., Vavuranakis M., Tsiamis E., Stefanadis C. Imaging of the vulnerable plaque: noninvasive and invasive techniques. Am J Med Sci 2008, 336:342-348.
28. Toutouzas K., Synetos A., Nikolaou C., Tsiamis E., Tousoulis D., Stefanadis C. Matrix metalloproteinases and vulnerable atheromatous plaque. Curr Top Med Chem 2012, 12:1166-1180.
29. Drakopoulou M., Toutouzas K., Michelongona A., Tousoulis D., Stefanadis C. Vulnerable plaque and inflammation: potential clinical strategies. Curr Pharm Des 2011, 17:4190-4209.
30. Casscells W., Hathorn B., David M., Krabach T., Vaughn W.K., McAllister H.A., et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996, 347:1447-1451.
31. Toutouzas K., Synetos A., Nikolaou C., Stathogiannis K., Tsiamis E., Stefanadis C. Microwave radiometry: a new non-invasive method for the detection of vulnerable plaque. Cardiovasc Diagn Ther 2012, 2:290-297.
32. Adams G.J., Simoni D.M., Bordelon C.B., Vick G.W., Kimball K.T., et al. Bilateral symmetry of human carotid artery atherosclerosis. Stroke 2002, 33:2575-2580.
33. Toutouzas K., Drakopoulou M., Mitropoulos J., Tsiamis E., Vaina S., Vavuranakis M., et al. Elevated plaque temperature in non-culprit de novo atheromatous lesions of patients with acute coronary syndromes. J Am Coll Cardiol 2006, 47:301-306.
34. Toutouzas K., Drakopoulou M., Vaina S., Stefanadis C. Significance of characterization of non-culprit lesions: an underscored clinical problem. Atherosclerosis 2007, 195:236-241.
35. Toutouzas K., Karanasos A., Riga M., Tsiamis E., Synetos A., Michelongona A., et al. Optical coherence tomography assessment of the spatial distribution of culprit ruptured plaques and thin-cap fibroatheromas in acute coronary syndrome. EuroIntervention 2012, 8:477-485.
36. Niccoli G., Ferrante G., Cosentino N., Conte M., Belloni F., Marino M., et al. Eosinophil cationic protein: a new biomarker of coronary atherosclerosis. Atherosclerosis 2010, 211:606-611.
37. Cox A.J., Agarwal S.D.M.H., Carr J.J., Freedman B.I., Bowden D.W. C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study. Diabet Med 2012, 29:767-770.
38. Corrado E., Rizzo M., Muratori I., Coppola G., Novo S. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res 2006, 37:1004-1009.
39. Wang T.J., Gona P., Larson M.G., Tofler G.H., Levy D., Newton-Cheh C., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631-2639.